Bridging with Cangrelor: A study on pre-procedure blood thinner use
Treatments studied
Part of Heart & circulation clinical trials.
This study looks at how well a certain blood thinner (cangrelor) works when used as a 'bridge' before surgery or another procedure. It is for people who already need to be on this medicine for a short time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently getting a standard dose of cangrelor (a blood thinner given through an IV) for at least two hours as part of your regular care.
- You do not need an urgent surgery.
- You are not pregnant, could be pregnant, or breastfeeding (if applicable).
- You have not taken any other blood thinner (such as Plavix, Effient, Brilinta, warfarin, or similar) in the last 48 hours.
- You do not have a known allergy to cangrelor or any of its ingredients (mannitol, sorbitol, microcrystalline cellulose).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways to manage blood thinners after a stent. It tests whether switching from stronger drugs (prasugrel or ticagrelor) to clopidogrel is safe and effective for long-term heart protection.
This trial tests switching from a standard blood thinner (clopidogrel) to a lower dose of a stronger one (prasugrel) in people who have had a stent placed and are at high risk for both bleeding and heart problems. The goal is to see if the switch better prevents clots while keeping bleeding risks low.
This study looks at the safest way to handle your blood thinners when you have a colonoscopy. It is for people with stable heart or blood vessel disease who take two blood thinners and need a routine screening or follow-up colonoscopy.
This study tests whether using a genetic test to choose your blood thinner (clopidogrel or ticagrelor) can improve how well the medication works. You may qualify if you have stable heart disease or a recent heart attack and are scheduled for a stent procedure.
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
This trial tests whether a lower dose of the blood thinner ticagrelor works better than clopidogrel in people with stable coronary artery disease who are getting a planned stent. It aims to find which drug is safer and more effective for preventing future heart problems.
Hear when a new Coronary Arterial Disease (CAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.